Improving PrEP access with telehealth and community partners
Part of Infections clinical trials.
This study looks at how telehealth can make PrEP (medication that helps prevent HIV) easier to get, by partnering with community organizations in Philadelphia. Researchers want to interview or survey clients and staff to understand what works and what could be improved.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 16 (for surveys) or 18 (for interviews).
- You live in the Philadelphia area now.
- You are involved with a partner community organization – as a client, staff member, or leader.
- You can understand the study details and agree to take part.
- You are not currently living with HIV.
- If you are a client taking a survey, you have used a TelePrEP Navigator to set up a telehealth appointment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at ways to improve PrEP (pre-exposure prophylaxis) care by helping clinic staff track and support patients better. It's for healthcare workers, managers, and data staff at certain PrEP clinics.
This study tests whether pharmacies can offer HIV prevention medications (PrEP/PEP) with remote nurse support. It aims to make HIV prevention easier to access in the community.
This study helps young people who are at risk for HIV get on PrEP—a daily pill or shot that prevents HIV. It tests different ways to help you start and stay on PrEP, with care available at clinics or in your community.
This study looks at offering HIV prevention medicines (PrEP) to patients visiting a family planning clinic. It aims to make it easier for people to access this care alongside their regular visit.
This study looks at how well long-acting injectable PrEP (a shot that prevents HIV) works for people who are at risk for HIV. Researchers want to understand the experience of patients and the healthcare staff who support them.
This trial tests whether telehealth support can help people who inject drugs start and stay on PrEP (HIV prevention medicine). You will join several sessions and follow-up visits to see if this approach works better than standard care.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.